Exscientia’s $674m AI Drug Discovery Collaboration with Merck KGaA

Georgio Naffaa Europe Legal Chronicle
Tagged:

Allen & Overy has advised Exscientia on its USD674 million AI drug discovery collaboration with Merck KGaA.Collaboration is set to harness Exscientia’s precision design capabilities to…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Georgio Naffaa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here